<?xml version="1.0" encoding="UTF-8"?>
<collection>
<dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:invenio="http://invenio-software.org/elements/1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:identifier>doi:10.2340/00015555-3905</dc:identifier><dc:language>eng</dc:language><dc:creator>Marron S.E.</dc:creator><dc:creator>Gomez-Barrera M.</dc:creator><dc:creator>Tomas-Aragones L.</dc:creator><dc:creator>Goni-Navarro A.</dc:creator><dc:creator>Vilarrasa-Rull E.</dc:creator><dc:creator>Diaz-Diaz R.M.</dc:creator><dc:creator>Garcia-Latasa De Aranibar F.J.</dc:creator><dc:creator>Campos-Rodenas R.</dc:creator><dc:creator>Fuentelsaz-Del-barrio V.</dc:creator><dc:creator>Gilaberte-Calzada Y.</dc:creator><dc:creator>Gracia-Cazaña T.</dc:creator><dc:creator>Morales-Callaghan A.M.</dc:creator><dc:creator>Ros-Abarca S.</dc:creator><dc:creator>Madrid-Alvarez M.B.</dc:creator><dc:creator>Puig L.</dc:creator><dc:title>Quality of life in hidradenitis suppurativa: Validation of the hsqol-24</dc:title><dc:identifier>ART-2021-126179</dc:identifier><dc:description>To date, there are no disease-specific instruments in Spanish to assess quality of life of patients with hidra-denitis suppurativa. A multicentre study was pre-viously carried out in Spain between 2016 and 2017 to develop the Hidradenitis Suppurativa Quality of Life-24 (HSQoL-24), a disease-specific questionnaire to assess quality of life in patients with hidradenitis suppurativa. The objectives of this study are to revali-date the HSQoL-24 in Spanish with a larger sample of patients, and to present the English version. In this multi centre study in Spain, patients with hidradenitis suppurativa completed the HSQoL-24, the Dermatology Life Quality Index and the Skindex-29. The Hurley staging system was used to assess the severity of the disease. Validation of the questionnaire was carried out in 130 patients, of whom 75 (57.7%) were women. This study demonstrates adequate values of reliability and validity of the HSQoL-24, confirming the previous test re-test validation and making this questionnaire one of wide clinical validity in terms of results perceiv-ed by patients.</dc:description><dc:date>2021</dc:date><dc:source>http://zaguan.unizar.es/record/151460</dc:source><dc:doi>10.2340/00015555-3905</dc:doi><dc:identifier>http://zaguan.unizar.es/record/151460</dc:identifier><dc:identifier>oai:zaguan.unizar.es:151460</dc:identifier><dc:identifier.citation>Acta Dermato-Venereologica 101, 8 (2021), [5 pp.]</dc:identifier.citation><dc:rights>by-nc</dc:rights><dc:rights>https://creativecommons.org/licenses/by-nc/4.0/deed.es</dc:rights><dc:rights>info:eu-repo/semantics/openAccess</dc:rights></dc:dc>

</collection>